An association of 27- and 40-kDa molecules with glycolipids that bind A-B bacterial enterotoxins to cultured cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1612, Issue 2, 2003, Pages 186-194

  Shimizu, Takeshi ^a   Hamabata, Takashi ^b   Yoshiki, Akemi ^c   Hori, Takeya ^c   Ito, Satoru ^c,e   Takeda, Yoshifumi ^d   Hayashi, Hideo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c FUJIREBIO INC   (Japan)

^d JISSEN WOMEN'S UNIVERSITY   (Japan)

^e JGS Japan Genome Solutions Inc   (Japan)

Author keywords

A B enterotoxin; Cholera toxin; Heat labile enterotoxin; Raft; Receptor; Shiga like toxin

Indexed keywords

BACTERIAL TOXIN; CHOLERA TOXIN; DETERGENT; ENTEROTOXIN; GLYCOLIPID; MEMBRANE PROTEIN; PROPIONIC ACID DERIVATIVE; SULFOSUCCINIMIDYL 2 (4 AZIDOSALICYLAMIDO) 1,3' DITHIOPROPIONATE; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CELL CULTURE; CELL STRAIN CACO 2; CELL TYPE; CHO CELL; CONTROLLED STUDY; CROSS LINKING; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; VERO CELL;

BACTERIA (MICROORGANISMS);

EID: 0038054049     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(03)00130-5     Document Type: Article

References (47)

1. Anderson R.G. The caveolae membrane system. Ann. Rev. Biochem. 67:1998;199-225.
2. Simons K., Ikonen E. Functional rafts in cell membranes. Nature. 387:1997;569-572.
3. Anderson R.G. Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10909-10913.
4. Manes S., Mira E., Gomez-Mouton C., Lacalle R.A., Keller P., Labrador J.P., Martinez A.C. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J. 18:1999;6211-6220.
5. Parton R.G., Joggerst B., Simons K. Regulated internalization of caveolae. J. Cell Biol. 127:1994;1199-1215.
6. Katagiri Y.U., Mori T., Nakajima H., Katagiri C., Taguchi T., Takeda T., Kiyokawa N., Fujimoto J. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J. Biol. Chem. 274:1999;35278-35282.
7. Orlandi P.A., Fishman P.H. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 141:1998;905-915.
8. Wolf A.A., Jobling M.G., Wimer-Mackin S., Ferguson-Maltzman M., Madara J.L., Holmes R.K., Lencer W.I. Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J. Cell Biol. 141:1998;917-927.
9. Paton J.C., Paton A.W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11:1998;450-479.
10. Kaper J.B., Morris J.G. Jr., Levine M.M. Cholera. Clin. Microbiol. Rev. 8:1995;48-86.
11. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:1988;45-50.
12. Moss J., Vaughan M. Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. J. Biol. Chem. 252:1977;2455-2457.
13. Moss J., Garrison S., Oppenheimer N.J., Richardson S.H. NAD-dependent ADP-ribosylation of arginine and proteins by Escherichia coli heat-labile enterotoxin. J. Biol. Chem. 254:1979;6270-6272.
14. Cassel D., Selinger Z. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. U. S. A. 74:1977;3307-3311.
15. Mallard F., Antony C., Tenza D., Salamero J., Goud B., Johannes L. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J. Cell Biol. 143:1998;973-990.
16. Johannes L., Goud B. Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum? Trends Cell Biol. 8:1998;158-162.
17. Lencer W.I., Hirst T.R., Holmes R.K. Membrane traffic and the cellular uptake of cholera toxin. Biochim. Biophys. Acta. 1450:1999;177-190.
18. Sandvig K., van Deurs B. Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J. 19:2000;5943-5950.
19. Lencer W.I. Microbes and microbial Toxins: paradigms for microbial-mucosal toxins. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin. Am. J. Physiol. 280:2001;G781-G786.
20. Sandvig K., van Deurs B. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett. 529:2002;49-53.
21. Wadolkowski E.A., Sung L.M., Burris J.A., Samuel J.E., O'Brien A.D. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect. Immun. 58:1990;3959-3965.
22. Tesh V.L., Burris J.A., Owens J.W., Gordon V.M., Wadolkowski E.A., O'Brien A.D., Samuel J.E. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61:1993;3392-3402.
23. Boerlin P., McEwen S.A., Boerlin-Petzold F., Wilson J.B., Johnson R.P., Gyles C.L. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:1999;497-503.
24. Nakajima H., Kiyokawa N., Katagiri Y.U., Taguchi T., Suzuki T., Sekino T., Mimori K., Ebata T., Saito M., Nakao H., Takeda T., Fujimoto J. Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J. Biol. Chem. 276:2001;42915-42922.
25. Louise C.B., Obrig T.G. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J. Infect. Dis. 172:1995;1397-1401.
26. Head S.C., Karmali M.A., Lingwood C.A. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J. Biol. Chem. 266:1991;3617-3621.
27. Clements J.D., Finkelstein R.A. Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures. Infect. Immun. 24:1979;760-769.
28. Clements J.D., Yancey R.J., Finkelstein R.A. Properties of homogeneous heat-labile enterotoxin from Escherichia coli. Infect. Immun. 29:1980;91-97.
29. Rodighiero C., Aman A.T., Kenny M.J., Moss J., Lencer W.I., Hirst T.R. Structural basis for the differential toxicity of cholera toxin and Escherichia coli heat-labile enterotoxin. Construction of hybrid toxins identifies the A2-domain as the determinant of differential toxicity. J. Biol. Chem. 274:1999;3962-3969.
30. Bowman C.C., Clements J.D. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids. Infect. Immun. 69:2001;1528-1535.
31. Noda M., Yutsudo T., Nakabayashi N., Hirayama T., Takeda Y. Purification and some properties of Shiga-like toxin from Escherichia coli 0157:H7 that is immunologically identical to Shiga toxin. Microb. Pathog. 2:1987;339-349.
32. Yutsudo T., Nakabayashi N., Hirayama T., Takeda Y. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3:1987;21-30.
33. Uesaka Y., Otsuka Y., Lin Z., Yamasaki S., Yamaoka J., Kurazono H., Takeda Y. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb. Pathog. 16:1994;71-76.
34. Guerrant R.L., Brunton L.L., Schnaitman T.C., Rebhun L.I., Gilman A.G. Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect. Immun. 10:1974;320-327.
35. Jacewicz M.S., Mobassaleh M., Gross S.K., Balasubramanian K.A., Daniel P.F., Raghavan S., McCluer R.H., Keusch G.T. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J. Infect. Dis. 169:1994;538-546.
36. Acheson D.W., Moore R., De Breucker S., Lincicome L., Jacewicz M., Skutelsky E., Keusch G.T. Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect. Immun. 64:1996;3294-3300.
37. Keusch J.J., Manzella S.M., Nyame K.A., Cummings R.D., Baenziger J.U. Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipid synthesis, predicts a family of alpha 1, 4-glycosyltransferases conserved in plants, insects, and mammals. J. Biol. Chem. 275:2000;25315-25321.
38. Devenish J., Gyles C., LaMarre J. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells. Can. J. Microbiol. 44:1998;28-34.
39. Jacewicz M.S., Acheson D.W., Mobassaleh M., Donohue-Rolfe A., Balasubramanian K.A., Keusch G.T. Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. J. Clin. Invest. 96:1995;1328-1335.
40. Nathan D.F., Burkhart S.R., Morin M.J. Increased cell surface EGF receptor expression during the butyrate-induced differentiation of human HCT-116 colon tumor cell clones. Exp. Cell Res. 190:1990;76-84.
41. Leder A., Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell. 5:1975;319-322.
42. Toscani A., Soprano D.R., Soprano K.J. Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes. J. Biol. Chem. 265:1990;5722-5730.
43. Henneberry R.C., Fishman P.H. Morphological and biochemical differentiation in HeLa cells. Effects of cycloheximide on butyrate-induced process formation and ganglioside metabolism. Exp. Cell Res. 103:1976;55-62.
44. Miyake M., Utsuno E., Noda M. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography. Anal. Biochem. 281:2000;202-208.
45. Angstrom J., Teneberg S., Karlsson K.A. Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11859-11863.
46. Holmgren J. Receptors for cholera toxin and Escherichia coli heat-labile enterotoxin revisited. Prog. Brain Res. 101:1994;163-177.
47. Hurley B.P., Jacewicz M., Thorpe C.M., Lincicome L.L., King A.J., Keusch G.T., Acheson D.W. Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect. Immun. 67:1999;6670-6677.